Eosinophilia: Difference between revisions

Line 8: Line 8:
*[[Allergic reaction]] or other hypsersensitivity/atopic state
*[[Allergic reaction]] or other hypsersensitivity/atopic state
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
*[[DRESS syndrome]]
*[[DRESS syndrome]], drug-induced
*[[Parasitic infection]]
*[[Parasitic infection]]
*[[Coccidioidomycosis]] and other fungal infections
*[[Coccidioidomycosis]] and other fungal infections
Line 16: Line 16:
*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])
*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])
*Interstitial nephritis
*Interstitial nephritis
*[[Arsenic]]
*[[Arsenic]], [[gold toxicity]]


==Evaluation==
==Evaluation==

Revision as of 18:37, 26 August 2019

Background

  • Defined usually as peripheral eosinophil count >0.5 x 109/L
  • Eosinophils normally comprise <7% of total WBC count

Clinical Features

Differential Diagnosis

Evaluation

Management

Disposition

See Also

External Links

References